Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ARICEPT
- Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics From Single Dose of Intramuscular (IM) and Subcutaneous (SC) Donepezil (GB-5001) Injections Versus Donepezil Oral Tablet (Aricept®) in Healthy Male Volunteers
- A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease
- Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Donepezil From Single Dose of GB-5001 IM Depot and Aricept® Oral Tablets in Healthy Male Volunteers
- Effect of Donepezil on Speech Recognition in Cochlear Implant Users
- A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.
- Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)
- Donepezil Versus Non-drug Treatment in Alzheimer's Disease.
- Crossover Pharmacokinetic (PK) Study of 5 and 10 mg Corplex™ Donepezil TDS Compared to 10 mg Aricept® in Healthy Volunteers
- Senolytic Therapy to Modulate Progression of Alzheimer's Disease
- Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy Adults
- Safety and Pharmacokinetic of Donepezil Pamoate in Healthy Subjects
- Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
- The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's
- Improving Walking Automaticity in Parkinson's Disease: Levodopa or Donepezil
- A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies
- Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease
- A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®
- A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease
- Combining Donepezil With Perceptual Learning in Normal and Amblyopic Human The Effect of Donepezil on Perceptual Learning in Adult Amblyopia
- Detecting an Early Response to Donepezil With Measures of Visual Attention
- Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers
- Memory and Mental Health in Aging
- A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®
- A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson Patients
- Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil
- Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease
- DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil
- A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease
- Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg
- Pilot Study of Sleep Therapy and Biomarkers in Children With Autism Spectrum Disorders
- Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).
- The Efficacy and Safety Study of High Dose Donepezil in Parkinson's Disease With Dementia
- A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)
- Donepezil Memory Preservation Post ECT
- Effect of Electroacupuncture Combined With Donepezil for Treating Alzheimer's Disease
- Multicenter Evaluation of Memory Remediation After TBI With Donepezil
- Effects of Donepezil on Regional Cerebral Blood Flow Following Aneurysmal Subarachnoid Haemorrhage
- Effects of Cholinergic Augmentation on Measures of Balance and Gait
- Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice
- Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease
- A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients
- Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318)
- Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults
- Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly
- Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fasting Condition
- Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fed Condition
- Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects
- Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil
- Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain
- Donepezil Effect on Visual Attention and Training
- Combination Treatment Study for Memory Impairment and Depression
- Treatment of Residual Amblyopia With Donepezil
- The Effect of Donepezil on Gait and Balance in Parkinson's Disease
- Bioequivalence Study for Donepezil Hydrochloride Tablets 10 mg Under Fed Condition
- Bioequivalence Study for Donepezil Hydrochloride 10 mg Tablets Under Fasting Condition
- Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior
- Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)
- Efficacy and Safety Study of Shenwu Capsule
- Donepezil Trial for Motor Recovery in Acute Stroke
- Donepezil 10 mg Tablets Under Fed Conditions
- Donepezil 10 mg Tablets Under Fasting Conditions
- Bioequivalence Study of Torrent Pharmaceutical Limited's Donepezil Hydrochloride Tablets Under Fed Conditions
- Bioequivalence Study of Torrent Pharmaceutical Limited's Donepezil Hydrochloride Tablets Under Fasting Conditions
- Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRI
- Comparative Research of Alzheimer's Disease Drugs
- Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia
- Pharmacokinetic Comparisons of Two Donepezil Formulations
- Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fed Conditions
- Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fasting Conditions
- 10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting Conditions
- 10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.
- Effect of Donepezil on Smoking
- An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia
- The Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute Mania
- Placebo-Controlled Crossover Study to Evaluate Donepezil and MK-3134 for Reversal of Cognitive Impairment Associated With Scopolamine Administration (3134-005)(COMPLETED)
- Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease
- Randomized Controlled Study of Donepezil in Fragile X Syndrome
- Does Memantine Improve Verbal Memory Task Performance in Subjects With Partial Epilepsy and Memory Dysfunction?
- A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of Cognition
- Drug-Drug Interaction Study With Aricept® (Donepezil)
- The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil
- Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease
- Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid
- Study Evaluating The Coadministration of Begacestat And Donepezil
- Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease
- Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-System
- Cholinergic Augmentation in Frequently Falling Subjects With Parkinson's Disease
- Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease
- Non-Interventional Study With Aricept® Evess
- BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)
- A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)
- Enhancing Rehabilitation After Stroke
- Donepezil and Memantine in Moderate to Severe Alzheimer's Disease
- Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease
- Mayo Acute Stroke Trial for Enhancing Recovery
- fMRI-behavioral Study of Cholinergic Augmentation With Donepezil in Healthy Sleep Deprived Adults
- Corticolimbic Degeneration and Treatment of Dementia
- Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
- Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10
- Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease
- Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease
- The Effect of Donepezil (Aricept(Registered Trademark)) on REM Sleep in Children With Autism
- Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment
- Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial
- A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes
- Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy
- A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies
- Supporting the Health of Adults Undergoing Orthopedic Surgery During the Recovery Period
- The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
- Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
- Open-Label Extension Study of 23 mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease
- Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
- A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)
- Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease
- Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults
- Neural Correlates In Mild Alzheimer's Disease
- Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease
- Use of Donepezil for Treatment of Cocaine Dependence
- Aricept to Improve Functional Tasks in Vascular Dementia
- Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease
- Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease
- Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept
- The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
- Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients
- The Effect of Donepezil on Sedation and Other Symptoms
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
- A fMRI(Functional Magnetic Resonance Imaging) Research Study to Learn More About Multiple Sclerosis and Individuals Potentially Experiencing Memory Difficulties
- EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)
- Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke
- An Open-Label Trial of Donepezil in Fragile X Syndrome
- Antidepressant Medication Plus Donepezil for Treating Late-life Depression
- The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia
- Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia
- Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients
- Mifepristone as Adjunctive Therapy in Alzheimer's Disease
- Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)
- The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
- Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
- Improving Memory in Patients With Multiple Sclerosis
- Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease
- Donepezil HCl & Cognitive Deficits in Autism
- Memory and Mental Health in Aging
- Treatment for Early Memory Loss
- Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon Alpha
- Donepezil to Treat Dementia in Parkinson's Disease
- Lipitor as a Treatment for Alzheimer's Disease
- Electrophysiologic Measures of Treatment Response in Alzheimer Disease
- Study of the Pathogenesis of Rett Syndrome
- Memory Impairment Study (Mild Cognitive Impairment Study)
Clinical trials list
click for details